• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » EMD Serono appoints Craig Millian SVP, Neurology And Immunology

EMD Serono appoints Craig Millian SVP, Neurology And Immunology

September 20, 2016
CenterWatch Staff

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, has announced the appointment of Craig Millian as senior vice president, Neurology and Immunology. Millian most recently served as senior vice president, head of U.S. Fertility and Endocrinology at EMD Serono. In his new role, he will lead the strategic direction of the company's U.S. Neurology and Immunology franchise.

"Craig is a dynamic leader with a proven track record of success," said Gary Zieziula, president and managing director of EMD Serono. "He has been instrumental in expanding our leadership in Fertility and Endocrinology, and he will bring that passion and expertise to the Neurology and Immunology business, furthering our commitment to improving care for people living with multiple sclerosis and other conditions as we advance our pipeline."

Millian joined EMD Serono in 2010 to lead the Fertility and Endocrinology marketing team. He previously served as vice president, Commercial at Vertex, where he helped design and build the commercial infrastructure, organizational capabilities and go-to-market plans in advance of launching the Vertex product pipeline. Prior to Vertex, he held commercial leadership roles at Pfizer and Sanofi. Millian holds an MBA from New York University and a degree in Finance from the University of Pennsylvania.

Drew Young, who previously served as senior vice president, Neurology and Immunology for EMD Serono, has recently been appointed to a new position within Merck KGaA, Darmstadt, Germany. He will serve as general manager and managing director, Merck KGaA, Darmstadt, Germany, Biopharma, Australia & New Zealand. Young joined EMD Serono in June 2014 and had a positive impact on the company's neurology and immunology performance.

EMD Serono's neurology franchise includes Rebif (interferon beta-1a), a prescribed interferon for patients with relapsing forms of MS new to therapy and switching therapy combined in the US.i Rebif has a well-established safety profile with more than 20 years of accrued clinical trial and patient experience. Since its approval in 2002, more than 130,000 people have chosen Rebif to treat their relapsing MS. In addition to providing this important treatment option, EMD Serono offers comprehensive support to patients through MS LifeLines. For more than 14 years, this award-winning patient support service has provided round-the-clock education and support for people living with relapsing MS.

The company also has a pipeline of products it is investigating in the immunology and neurology space.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing